Cargando…

Engineering nanoparticles to overcome barriers to immunotherapy

Advances in immunotherapy have led to the development of a variety of promising therapeutics, including small molecules, proteins and peptides, monoclonal antibodies, and cellular therapies. Despite this wealth of new therapeutics, the efficacy of immunotherapy has been limited by challenges in targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Toy, Randall, Roy, Krishnendu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689503/
https://www.ncbi.nlm.nih.gov/pubmed/29313006
http://dx.doi.org/10.1002/btm2.10005

Ejemplares similares